CV Genetics Flashcards
What is pleitropy?
When one genetic mutation effects multiple traits/phenotypes
What is genetic heterogeniety?
When one disease can be caused by multiple genetic mutations
Wht is variable expressivity?
Individuals have variable expression of diseases
What is RWS?
A genetic disorder that causes LQTS w/ no deafness
AD; 50% penetrance, genetic heterogeniety (10 genes)
Most common RWS mutation
KCNQ1 >60% of cases; has highest incidence of cardiac events
Which RWS mutation has symptoms triggered by sleep?
SCN5A; Na channel mutation
RWS Treatment
Beta-blockers
Pacemakers
ICD
Jervel and Lange-Nielson Syndrome
AR; congenital LQTS w/ bilateral sensorineural deafness
Jervell and Lange-Nielson Syndrome mutations
KCNQ1 = 90% (LQTS type 1) KCNE1 = 10% (LQTS type 5)
Jervell and Lange-Nielson Syndrome mortality/complications
- Increased risk of SIDS
- >50% of untreated die before 15 years old
Current LQTS genetic testing detection rate
75%; 25% of LQTS do not have a detectable gene mutation
Does a negative genetic test rule out LQTS?
No
What is Brugada syndrome
Disorder characterized by ST-segment elevation in leads V1-V3
Syncope, SIDS, SUNDS
Major genetic mutation in Brugada
SCN5A gene; alpha subunit of Na channel
What is catecholaminergic polymorphic ventricular tachycardia (CPVT)
Bidirectional polymorphic ventricular tachycardia, can become VFib
-Exercise or emotional trigger causes syncope
CPVT mutation
RYR2 (ryanodine receptor channel) = AD inheritance
CASQ2 (calsequesterin of SR) = AR inheritance
HCM inheritance
AD inheritance
- 50-60% with a famhx have sarcomere gene mutation
- 20-30% without a famhx have a sarcomere gene mutation
HCM mutated genes
MYH17 - myosin head; classic
MYBPC3; later age of onset
TNNT2; mild or absent LVH, higher risk of arrhythmias and SCD
What two diseases resemble HCM
Danon disease
Fabry disease
Which HCM mutation has highest risk of arrhythmias
TNNT2
What is the primary indication of cardiac transplantation
DCM
What is idiopathic DCM
All acquired causes excluded, except genetic causes
DCM detection rate
30%; high genetic heterogeneity; 20 genes, most are AD
LMNA mutation
DCM; prominent conduction disease
Pleiotrophic gene; involved in other diseases
When is screening recommended for cardiomyopathy
- Asymptomatic first degree relatives
- Relatives known to carry the mutations
HCM screening
Positive or negative:
- yearly during puberty
- Every 3 years until 30
- Every 5 years after 30 (if negative, only when symptomatic)
DCM screening
Positive mutation:
- yearly during childhood
- every 1-3 years during adulthood
Negative mutation:
-every 3-5 years
Familial hypercholesterolemia levels
Untreated adults:
-LDL > 190 mg/dL or TC > 310
Untreated children:
-LDL >160, TC >230
Homozygous mutation:
TC > 500
Familial hypercholesterolemia mutations
LDL-R = most common
ApoB
PCSK9 = least common
HeFH = AD HoFH = AR